Is Travere Therapeutics, Inc. (TVTX) a Buy, Sell, or Hold?
Travere Therapeutics, Inc.
NASDAQ:TVTX
$57.06 USD
$0.77 (1.37%)
- Volume
- 890.17K
- Average Volume
- 2.52M
- Market Capitalization
- $5.31B
- P/E Ratio
- -116.45
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $60.10
- Year Low
- $15.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.13
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.69%
Investors Holding
9
change: -270 | last: 279
Increased Positions
6
change: -135 | last: 141
Reduced Positions
0
change: -94 | last: 94
New Positions
2
change: -46 | last: 48
Sold Positions
256
change: 187 | last: 69
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -71.8215 | last: 0.7182
Total Invested
36.22M
TVTX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $38.21 | 89.21M | $3.41B | $93.04M | $328.73M | $3.64B |
| 2024-12-31 | $17.42 | 78.89M | $1.37B | $58.54M | $401.58M | $1.72B |
| 2023-12-31 | $8.99 | 74.27M | $667.66M | $58.18M | $404.78M | $1.01B |
| 2022-12-31 | $21.03 | 63.76M | $1.34B | $61.69M | $407.49M | $1.69B |
| 2021-12-31 | $31.04 | 59.83M | $1.86B | $165.75M | $261.99M | $1.95B |
| 2020-12-31 | $27.26 | 47.54M | $1.3B | $84.77M | $244.03M | $1.45B |
| 2019-12-31 | $14.20 | 42.34M | $601.23M | $62.44M | $214.87M | $753.66M |
| 2018-12-31 | $22.63 | 40.42M | $914.8M | $102.87M | $217.55M | $1.03B |
| 2017-12-31 | $21.07 | 38.77M | $816.88M | $99.39M | $45.08M | $762.56M |
| 2016-12-31 | $18.93 | 37M | $700.37M | $41M | $44.42M | $703.79M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29.71 | 91.87M | $2.73B | $78.36M | $327.66M | $2.98B |
| 2025-12-31 | $38.21 | 90.29M | $3.45B | $93.04M | $339.87M | $3.7B |
| 2025-09-30 | $23.90 | 89.23M | $2.13B | $110.93M | $329.75M | $2.35B |
| 2025-06-30 | $14.80 | 88.95M | $1.32B | $75.15M | $399.57M | $1.64B |
| 2025-03-31 | $17.92 | 88.36M | $1.58B | $61.9M | $400.46M | $1.92B |
| 2024-12-31 | $17.42 | 83.1M | $1.45B | $58.54M | $401.58M | $1.79B |
| 2024-09-30 | $13.99 | 77.78M | $1.09B | $36.41M | $402.43M | $1.45B |
| 2024-06-30 | $8.28 | 77.5M | $641.7M | $32.29M | $403.23M | $1.01B |
| 2024-03-31 | $7.31 | 77.14M | $563.87M | $43.25M | $404.02M | $924.63M |
| 2023-12-31 | $8.99 | 76.47M | $687.51M | $58.18M | $404.78M | $1.03B |
| 2023-09-30 | $8.94 | 76.31M | $682.17M | $144.24M | $405.48M | $943.41M |
| 2023-06-30 | $15.36 | 76M | $1.17B | $70.87M | $406.17M | $1.5B |